SKYTROFA
Total Payments
$5.8M
Transactions
4,364
Doctors
818
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $3.3M | 1,971 | 620 |
| 2022 | $2.4M | 2,393 | 450 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.9M | 809 | 84.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $473,584 | 218 | 8.2% |
| Consulting Fee | $210,519 | 67 | 3.6% |
| Travel and Lodging | $124,994 | 555 | 2.2% |
| Food and Beverage | $92,932 | 2,691 | 1.6% |
| Education | $273.76 | 24 | 0.0% |
Payments by Type
Research
$4.9M
809 transactions
General
$902,303
3,555 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| foresiGHt | Ascendis Pharma Inc | $1.3M | 0 |
| enliGHten | Ascendis Pharma, Inc. | $1.1M | 0 |
| foresiGHt | Ascendis Pharma, Inc. | $943,826 | 0 |
| New InsiGHts | Ascendis Pharma Inc | $590,868 | 0 |
| foresiGHt extension | Ascendis Pharma Inc | $478,392 | 0 |
| enliGHten | Ascendis Pharma Inc | $469,066 | 0 |
Top Doctors Receiving Payments for SKYTROFA — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pediatrics | Cincinnati, OH | $533.70 | 4 |
| , M.D | Pediatric Endocrinology | Coral Gables, FL | $519.05 | 13 |
| , D.O | Endocrinology, Diabetes & Metabolism | Maywood, IL | $499.36 | 36 |
| , D.O | Pediatric Endocrinology | Greenwood Village, CO | $489.10 | 10 |
| , MD | Pediatrics | El Paso, TX | $469.94 | 12 |
| , MD | Pediatric Endocrinology | Atlanta, GA | $427.75 | 14 |
| , MD | Pediatric Endocrinology | Houston, TX | $425.05 | 14 |
| , MD | Pediatric Endocrinology | Sacramento, CA | $421.42 | 12 |
| , MD | Pediatric Endocrinology | Austin, TX | $421.31 | 6 |
| , MD | Pediatric Endocrinology | Corpus Christi, TX | $420.62 | 14 |
| , MD | Pediatric Endocrinology | Oxnard, CA | $398.12 | 11 |
| Debara Preston | Pediatrics | Barrington, IL | $374.34 | 6 |
| , M.D | Pediatrics | Chicago, IL | $372.26 | 4 |
| , M.D | Pediatrics | Detroit, MI | $371.45 | 12 |
| , MD | Pediatric Endocrinology | Long Beach, CA | $366.49 | 11 |
| , MD | Pediatric Endocrinology | Miami, FL | $366.25 | 3 |
| , MD | Endocrinology, Diabetes & Metabolism | Tarzana, CA | $366.15 | 15 |
| , M.D | Pediatrics | Fort Lauderdale, FL | $364.25 | 11 |
| , M.D | Pediatrics | Coral Gables, FL | $359.58 | 12 |
| , M.D | Pediatric Endocrinology | Coral Gables, FL | $358.99 | 8 |
| , M.D | Pediatric Endocrinology | San Antonio, TX | $354.63 | 17 |
| , CPNP | Pediatrics | Atlanta, GA | $354.27 | 11 |
| , M.D | Pediatrics | Idaho Falls, ID | $352.44 | 15 |
| , ARNP | Primary Care | Margate, FL | $346.24 | 6 |
| , NP | Pediatrics | Indianapolis, IN | $345.21 | 4 |
Ad
Manufacturing Companies
- Ascendis Pharma Inc $3.3M
- Ascendis Pharma, Inc. $2.4M
Product Information
- Type Drug
- Total Payments $5.8M
- Total Doctors 818
- Transactions 4,364
About SKYTROFA
SKYTROFA is a drug associated with $5.8M in payments to 818 healthcare providers, recorded across 4,364 transactions in the CMS Open Payments database. The primary manufacturer is Ascendis Pharma, Inc..
Payment data is available from 2022 to 2023. In 2023, $3.3M was paid across 1,971 transactions to 620 doctors.
The most common payment nature for SKYTROFA is "Unspecified" ($4.9M, 84.4% of total).
SKYTROFA is associated with 6 research studies, including "foresiGHt" ($1.3M).